What are the guidelines for managing acute ischemic and hemorrhagic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Stroke Management

Initial Assessment and Imaging

All patients with suspected stroke must undergo immediate non-contrast CT scan to differentiate ischemic from hemorrhagic stroke before initiating any therapy, with a target door-to-needle time of less than 60 minutes in 90% of treated patients. 1

  • ECG should be performed to assess baseline cardiac rhythm, but this must not delay thrombolysis assessment 1
  • CT angiography should be performed immediately after non-contrast CT in patients presenting within 6 hours who are potential candidates for endovascular thrombectomy to identify large vessel occlusions 1, 2

Acute Ischemic Stroke Management

Intravenous Thrombolysis with Alteplase (rtPA)

Eligible patients must receive intravenous alteplase as soon as possible after hospital arrival, ideally within 3 hours of symptom onset, with extension to 4.5 hours in selected patients. 1, 2

Dosing and administration:

  • Standard dose is 0.9 mg/kg (maximum 90 mg total): 10% as IV bolus over 1 minute, remaining 90% as IV infusion over 60 minutes 1, 2
  • Lower doses (0.6 mg/kg) are NOT recommended despite reduced hemorrhage risk, as they failed to demonstrate non-inferiority for death and disability outcomes 3

Critical blood pressure requirements:

  • Blood pressure MUST be lowered and maintained below 185/110 mmHg BEFORE rtPA administration 1, 2
  • Blood pressure MUST be maintained below 180/105 mmHg for at least 24 hours AFTER treatment 1, 2
  • These strict thresholds are non-negotiable for thrombolysis eligibility 1

Key contraindications and risk factors for hemorrhagic transformation:

  • Severe initial clinical deficit (higher NIHSS scores) increases hemorrhagic infarction risk 2.5-fold 4
  • Early ischemic changes on CT increase hemorrhagic infarction risk 3.5-fold 4
  • Increasing age and rtPA treatment itself increase parenchymal hemorrhage risk 4
  • Symptomatic intracerebral hemorrhage occurs in approximately 2% of standard-dose treated patients 3

Endovascular Thrombectomy (EVT)

EVT is indicated for patients with large vessel occlusions, including both those who have received IV alteplase and those ineligible for IV alteplase. 1, 2

  • CT angiography must be performed to identify large vessel occlusions amenable to EVT 1, 2
  • EVT should be delivered within a coordinated system with rapid neurovascular imaging access and specialized neurointerventional expertise 1

Antiplatelet Therapy

Oral aspirin 325 mg should be administered within 24-48 hours after stroke onset for patients NOT receiving thrombolysis. 1, 2

  • Aspirin must NOT be administered within 24 hours of rtPA treatment 1, 2
  • Urgent anticoagulation is NOT recommended for acute ischemic stroke due to increased bleeding risk 2

Blood Pressure Management in Ischemic Stroke

For patients NOT receiving thrombolysis, withhold antihypertensive medications unless systolic BP >220 mmHg or diastolic BP >120 mmHg. 1, 2

  • A reasonable goal is to lower BP by 15% during the first 24 hours in patients with markedly elevated BP not receiving thrombolysis 1
  • Very high BP (>185/110 mmHg) must be treated in patients eligible for thrombolytic therapy 1, 2

Acute Hemorrhagic Stroke Management

Blood Pressure Management in Intracerebral Hemorrhage (ICH)

For ICH patients with systolic BP between 150-220 mmHg without contraindications, acute lowering of systolic BP to 140 mmHg is safe and may improve functional outcomes. 2

  • Blood pressure should be assessed upon ED arrival and every 15 minutes until stable 2

Reversal of Coagulopathy

Patients with severe coagulation factor deficiency or severe thrombocytopenia must receive appropriate factor replacement therapy or platelets. 2

For patients on vitamin K antagonists with elevated INR:

  • Immediately discontinue the medication 2
  • Administer therapy to replace vitamin K-dependent factors 2
  • Correct INR 2
  • Give intravenous vitamin K 2

Management of Increased Intracranial Pressure

Surgical decompression and evacuation is recommended for large cerebellar infarctions causing brainstem compression and hydrocephalus. 1, 2

  • Osmotherapy and hyperventilation are recommended for patients deteriorating from increased intracranial pressure 1, 2
  • Corticosteroids are NOT recommended for managing cerebral edema following ischemic stroke 1

Supportive Care (Both Stroke Types)

Temperature Management

  • Normothermia is preferred; treat fever >38°C (sources recommend >37.5°C or >38°C) 1, 2

Glucose Management

  • Treat hypoglycemia (blood glucose <60 mg/dL) to achieve normoglycemia 1, 2
  • Treat hyperglycemia to achieve blood glucose 140-180 mg/dL 1, 2

Airway and Oxygenation

  • Provide airway support and ventilatory assistance for patients with decreased consciousness or bulbar dysfunction 1, 2
  • Administer supplemental oxygen to maintain oxygen saturation >94% 1, 2

Hydration and Nutrition

  • Correct hypovolemia with intravenous normal saline 1, 2
  • Perform formal dysphagia screening before initiating oral intake to reduce pneumonia risk 2

Complication Prevention

  • Initiate intermittent pneumatic compression for venous thromboembolism prevention on day of hospital admission 2
  • Early mobilization is strongly recommended to prevent complications 1, 2

Stroke Unit Care

  • Comprehensive stroke unit care with specialized rehabilitation should be initiated as early as medically possible 1
  • Manage modifiable risk factors including blood pressure and cholesterol 1
  • Prescribe appropriate antithrombotic therapy based on stroke etiology 1

References

Guideline

Acute Stroke Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Manajemen Stroke Iskemik dan Hemoragik

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.